ATE447939T1 - Dosierungsformen enthaltend thyroidhormone und deren herstellungsverfahren - Google Patents

Dosierungsformen enthaltend thyroidhormone und deren herstellungsverfahren

Info

Publication number
ATE447939T1
ATE447939T1 AT03029729T AT03029729T ATE447939T1 AT E447939 T1 ATE447939 T1 AT E447939T1 AT 03029729 T AT03029729 T AT 03029729T AT 03029729 T AT03029729 T AT 03029729T AT E447939 T1 ATE447939 T1 AT E447939T1
Authority
AT
Austria
Prior art keywords
thyroid hormones
production process
dosage forms
forms containing
containing thyroid
Prior art date
Application number
AT03029729T
Other languages
English (en)
Inventor
Martino Alessandro Di
Angel Mateo
Alberto Garavani
Maurizio Marchiorri
Original Assignee
Altergon Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32448935&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE447939(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Altergon Sa filed Critical Altergon Sa
Application granted granted Critical
Publication of ATE447939T1 publication Critical patent/ATE447939T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03029729T 2002-12-27 2003-12-23 Dosierungsformen enthaltend thyroidhormone und deren herstellungsverfahren ATE447939T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002777A ITMI20022777A1 (it) 2002-12-27 2002-12-27 Formulazioni farmaceutiche per ormoni tiroidei e procedimenti per il loro ottenimento.

Publications (1)

Publication Number Publication Date
ATE447939T1 true ATE447939T1 (de) 2009-11-15

Family

ID=32448935

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03029729T ATE447939T1 (de) 2002-12-27 2003-12-23 Dosierungsformen enthaltend thyroidhormone und deren herstellungsverfahren

Country Status (10)

Country Link
US (1) US7691411B2 (de)
EP (1) EP1433478B1 (de)
JP (1) JP4851064B2 (de)
AT (1) ATE447939T1 (de)
CA (1) CA2454050C (de)
DE (1) DE60329968D1 (de)
DK (1) DK1433478T3 (de)
ES (1) ES2334777T3 (de)
IT (1) ITMI20022777A1 (de)
SI (1) SI1433478T1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7163918B2 (en) 2000-08-22 2007-01-16 New River Pharmaceuticals Inc. Iodothyronine compositions
ITMI20022394A1 (it) 2002-11-13 2004-05-14 Bracco Spa Uso di triiodotironina 3-solfato come farmaco ad attivita' tireomimetica e relative formulazioni farmaceutiche.
ITMI20110713A1 (it) 2011-04-29 2012-10-30 Bracco Imaging Spa Processo per la preparazione di un derivato solfatato di3,5-diiodo-o-[3-iodofenil]-l-tirosina
CN1882327A (zh) * 2003-11-19 2006-12-20 症变治疗公司 含磷的新的拟甲状腺素药
ITMI20041317A1 (it) * 2004-06-30 2004-09-30 Ibsa Inst Biochimique Sa Formulazioni farmaceutiche per la somministrazione sicura di farmaci utilizzati nel trattamento della tossicodipendenza e procedimento per il loro ottenimento
MX2007014502A (es) 2005-05-26 2008-02-07 Metabasis Therapeutics Inc Tiromimeticos para el tratamiento de enfermedades del higado graso.
WO2006128056A2 (en) * 2005-05-26 2006-11-30 Metabasis Therapeutics, Inc. Novel phosphinic acid-containing thyromimetics
IT1395454B1 (it) * 2009-03-24 2012-09-21 Altergon Sa Composizioni e forme farmaceutiche per somministrazione orale di ormoni tiroidei in grado di contrastare l'azione di agenti sequestranti nel tratto gastrointestinale
CN107635546B (zh) * 2015-05-19 2020-08-25 阿尔特刚股份有限公司 四碘甲状腺原氨酸的液体药物制剂
JP2020500199A (ja) 2016-11-21 2020-01-09 バイキング・セラピューティクス・インコーポレイテッド グリコーゲン蓄積症の治療方法
AU2018280118B2 (en) 2017-06-05 2021-07-15 Viking Therapeutics, Inc. Compositions for the treatment of fibrosis
ES3053674T3 (en) 2018-03-22 2026-01-23 Viking Therapeutics Inc Crystalline forms and methods of producing crystalline forms of a compound
BR112021004199A2 (pt) 2018-09-07 2021-05-25 R.P. Scherer Technologies, Llc estabilização de formas de dosagem à base de lipídio sólido ou semissólido através da cura e da adição de tensoativo(s) de baixo teor de hlb
WO2020117962A1 (en) 2018-12-05 2020-06-11 Viking Therapeutics, Inc. Compositions for the treatment of fibrosis and inflammation
EP4121036A4 (de) * 2020-03-18 2024-04-10 R.P. Scherer Technologies, LLC Weichgelkapseln
US12451021B2 (en) 2022-08-04 2025-10-21 The Mitre Corporation Microscale weather hazard products for urban aviation transportation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6191M (de) 1966-02-18 1968-07-22
DE4026600A1 (de) * 1990-08-23 1992-02-27 Henning Berlin Gmbh Mittel zur tsh-suppression und behandlung von struma
JPH0952850A (ja) * 1995-06-09 1997-02-25 Meiji Seika Kaisha Ltd グミ製剤
JPH10130140A (ja) * 1996-11-01 1998-05-19 Meiji Seika Kaisha Ltd グミ製剤の製造方法
US6365180B1 (en) * 1998-01-20 2002-04-02 Glenn A. Meyer Oral liquid compositions
US6395299B1 (en) * 1999-02-12 2002-05-28 Biostream, Inc. Matrices for drug delivery and methods for making and using the same
JP2000279107A (ja) * 1999-03-30 2000-10-10 Lion Corp 非う蝕性易嚥下組成物並びにそれを用いた食品用組成物及び医薬品用組成物
US6852688B2 (en) * 2000-03-10 2005-02-08 University Of Florida Compositions for treating diabetic retinopathy and methods of using same
US6790453B2 (en) * 2001-03-14 2004-09-14 Mccormick & Company, Inc. Encapsulation compositions and process for preparing the same
GB0111314D0 (en) 2001-05-09 2001-07-04 Karobio Ab Dermatological formulations
ITMI20011401A1 (it) 2001-07-02 2003-01-02 Altergon Sa Formulazioni farmaceutiche per ormoni tiroidei

Also Published As

Publication number Publication date
SI1433478T1 (sl) 2010-03-31
EP1433478A1 (de) 2004-06-30
DK1433478T3 (da) 2010-02-01
JP4851064B2 (ja) 2012-01-11
JP2004210780A (ja) 2004-07-29
CA2454050C (en) 2013-01-29
US20040219218A1 (en) 2004-11-04
DE60329968D1 (de) 2009-12-24
US7691411B2 (en) 2010-04-06
CA2454050A1 (en) 2004-06-27
EP1433478B1 (de) 2009-11-11
ITMI20022777A1 (it) 2004-06-28
ES2334777T3 (es) 2010-03-16

Similar Documents

Publication Publication Date Title
ATE447939T1 (de) Dosierungsformen enthaltend thyroidhormone und deren herstellungsverfahren
BRPI0418228A (pt) forma de dosagem, e, métodos de tratamento de dor e de episódios de dor incidente de cáncer, e de preparação de um tablete para administração bucal, gengival ou sublingual de fentanil
CY1106430T1 (el) Φαρμακα για εισπνοη που πepιλαμβανουν βηταμιμητικα και αντιχολινepγικο
SE0301700D0 (sv) Novel compounds
DE602005010788D1 (de) Pharmazeutische Zusammensetzungen zur sicheren Verabreichung von bei der Behandlung von Drogenabhängigkeit verwendeten Arzneimitteln
ATE312621T1 (de) Pharmazeutische formulierungen von thyroidhormonen
ATE359077T1 (de) Orale gabe von 6-hydroxy-oxymorphon als analgetikum
CY1110558T1 (el) Σπειροκυκλικα παραγωγα κυκλοεξανιου
IL164135A (en) 4-anilino quinazoline derivatives as antiproliferative agents, process for their preparation, pharmaceutical compositions containing such derivatives and use thereof for the preparation of medicaments for the treatment of cancer
NO20006007L (no) Fremgangsmåte til dosering av et medikament, samt doseringsform
HRP20041152B1 (hr) Farmaceutske formulacije
MXPA05011076A (es) Derivados de quinazolina para el tratamiento de cancer.
SG167657A1 (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
CY1108401T1 (el) Παραγωγα πυρρολοϊμιδαζολης, η παρασκευη τους, φαρμακευτικες συνθεσεις που τα περιεχουν και η χρηση τους ως νοοτροπικων παραγοντων
UY27757A1 (es) Medicamento que contiene betamiméticos y un nuevo anticolinérgico.
SE0303571D0 (sv) Medical product for moisture-sensitive medicaments
ATE453382T1 (de) Pulver zur nasalen verabreichung von wirkstoffen
TW200505452A (en) Chemical compounds
CY1110913T1 (el) Παραγωγα 2-πυρρολιδιν-2-υλο-[1,3,4]-οξαδιαζολης και η χρησιμοποιηση τους σαν αντικαταθλιπτικα
CY1107231T1 (el) Υποκατεστημενα παραγωγα 4-αμινοκυκλοεξανολης
EP1503748A4 (de) Arzneimittel zur linderung durch taxan induzierte neurotoxizität
DE69422712D1 (de) Tris-platin-komplexe
ATE400257T1 (de) Stabile pharmazeutische zusammensetzung mit linezolid form iv
DK1730144T3 (da) Substituerede 1,4,8-triazaspiro[4.5]decan-2-on-forbindelser
BR0307703A (pt) Composições de medicamentos na base de agentes anticolinérgicos e inibidores de quinase de egfr

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1433478

Country of ref document: EP